Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases

NCT01151644 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

5000

Enrollment

OTHER

Sponsor class

Conditions

Rheumatoid Arthritis
Spondyloarthritis
Systemic Lupus Erythematosus (SLE)
Dermatomyositis (DM)
DMixed Connective Tissue Disease
Systemic Vasculitis
Systemic Sclerosis (SSc)
Sjögren's Syndrome
Antiphospholipid Syndrome
Juvenile Idiopathic Arthritis
Juvenile SLE
Juvenile DM

Interventions

BIOLOGICAL: Anti-pandemic H1N1 influenza vaccine

Sponsor

University of Sao Paulo

Collaborators

[object Object]